On the whole, these data indicate a possible effectiveness ofGMI in the treatment of stroke. We think that the real efficacy of the drug will be demonstrated not only by a larger study, but also through more selective criteria regarding the stroke (ischaemic or haemorrhagic) and the time of therapy (beginning and duration).

Appollonio, I., Frattola, L., Massarotti, M. (1989). Trial of ganglioside GM1 in acute stroke. JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY, 52(5), 685-686.

Trial of ganglioside GM1 in acute stroke

Appollonio, I
Primo
;
Frattola, L
Secondo
;
1989

Abstract

On the whole, these data indicate a possible effectiveness ofGMI in the treatment of stroke. We think that the real efficacy of the drug will be demonstrated not only by a larger study, but also through more selective criteria regarding the stroke (ischaemic or haemorrhagic) and the time of therapy (beginning and duration).
Lettera in rivista
Acute Disease; Cerebrovascular Disorders; G(M1) Ganglioside; Humans
English
1989
52
5
685
686
open
Appollonio, I., Frattola, L., Massarotti, M. (1989). Trial of ganglioside GM1 in acute stroke. JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY, 52(5), 685-686.
File in questo prodotto:
File Dimensione Formato  
685.2.full.pdf

accesso aperto

Descrizione: Articolo principale
Dimensione 379.25 kB
Formato Adobe PDF
379.25 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/202393
Citazioni
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 1
Social impact